D.G. Haller

1.1k total citations
28 papers, 805 citations indexed

About

D.G. Haller is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, D.G. Haller has authored 28 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in D.G. Haller's work include Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (9 papers) and Neuroendocrine Tumor Research Advances (4 papers). D.G. Haller is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (9 papers) and Neuroendocrine Tumor Research Advances (4 papers). D.G. Haller collaborates with scholars based in United States, United Kingdom and Italy. D.G. Haller's co-authors include Paul J. Catalano, Roger A. Graham, Avital Cnaan, Paul P. Carbone, Rajesh Ramanathan, R. G. Hahn, Richard M. Hansen, Weijing Sun, D C Tormey and A.B. Benson and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and JNCI Journal of the National Cancer Institute.

In The Last Decade

D.G. Haller

28 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.G. Haller United States 12 539 291 176 173 125 28 805
Nathalie Théou–Anton France 14 362 0.7× 322 1.1× 79 0.4× 138 0.8× 115 0.9× 28 666
Marta Martín-Richard Spain 17 483 0.9× 238 0.8× 190 1.1× 80 0.5× 54 0.4× 42 708
Emmanuelle Samalin France 16 562 1.0× 353 1.2× 201 1.1× 111 0.6× 35 0.3× 75 827
Mona Fouad Egypt 16 638 1.2× 278 1.0× 95 0.5× 180 1.0× 74 0.6× 32 896
Natsuko Okita Japan 20 855 1.6× 518 1.8× 271 1.5× 236 1.4× 98 0.8× 110 1.3k
Yen‐Yang Chen Taiwan 17 342 0.6× 241 0.8× 300 1.7× 121 0.7× 54 0.4× 70 785
Fausto Barbieri Italy 22 757 1.4× 780 2.7× 134 0.8× 112 0.6× 66 0.5× 64 1.2k
Nozomu Machida Japan 20 819 1.5× 802 2.8× 429 2.4× 255 1.5× 134 1.1× 135 1.4k
John C. McAuliffe United States 14 326 0.6× 429 1.5× 408 2.3× 133 0.8× 81 0.6× 33 883
Günther Klautke Germany 19 605 1.1× 467 1.6× 456 2.6× 141 0.8× 26 0.2× 69 1.0k

Countries citing papers authored by D.G. Haller

Since Specialization
Citations

This map shows the geographic impact of D.G. Haller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.G. Haller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.G. Haller more than expected).

Fields of papers citing papers by D.G. Haller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.G. Haller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.G. Haller. The network helps show where D.G. Haller may publish in the future.

Co-authorship network of co-authors of D.G. Haller

This figure shows the co-authorship network connecting the top 25 collaborators of D.G. Haller. A scholar is included among the top collaborators of D.G. Haller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.G. Haller. D.G. Haller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chu, Edward, D.G. Haller, Thomas H. Cartwright, et al.. (2014). Epidemiology and natural history of central venous access device use and infusion pump function in the NO16966 trial. British Journal of Cancer. 110(6). 1438–1445. 6 indexed citations
2.
Tempero, Margaret A., Jordan Berlin, Michel Ducreux, et al.. (2011). Pancreatic cancer treatment and research: an international expert panel discussion. Annals of Oncology. 22(7). 1500–1506. 47 indexed citations
3.
4.
Mahmoud, N., Rosemarie Mick, Weijing Sun, et al.. (2006). 2178. International Journal of Radiation Oncology*Biology*Physics. 66(3). S308–S308. 1 indexed citations
5.
Haller, D.G.. (2003). New perspectives in the management of pancreas cancer. Seminars in Oncology. 30(4 Suppl 11). 3–10. 39 indexed citations
6.
Sun, Weijing & D.G. Haller. (2001). Recent Advances in the Treatment of Gastric Cancer. Drugs. 61(11). 1545–1551. 25 indexed citations
7.
O'Dwyer, P J, James Stevenson, D.G. Haller, N Rotman, & Bruce J. Giantonio. (2001). Follow-up of stage B and C colorectal cancer in the United States and France. Seminars in Oncology. 28(1B). 45–49. 3 indexed citations
8.
9.
Ramanathan, Rajesh, Avital Cnaan, R. G. Hahn, Paul P. Carbone, & D.G. Haller. (2001). Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282. Annals of Oncology. 12(8). 1139–1143. 144 indexed citations
10.
Siegfried, J., G. Wellis, Stefan Scheib, et al.. (2001). Palliative treatment of brain metastases with gamma knife. Therapeutische Umschau. 58(7). 413–418. 2 indexed citations
11.
Haller, D.G.. (2000). Safety of oxaliplatin in the treatment of colorectal cancer.. PubMed. 14(12 Suppl 11). 15–20. 35 indexed citations
12.
Witte, Robert S., Stuart R. Lipsitz, Robert F. Asbury, et al.. (1999). A Phase II Trial of Homoharringtonine and Caracemide in the Treatment of Patients with Advanced Large Bowel Cancer. Investigational New Drugs. 17(2). 173–177. 16 indexed citations
13.
Shapiro, Jeremy, Nancy Harold, J. Michael Hamilton, et al.. (1999). A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma.. PubMed. 5(9). 2399–408. 4 indexed citations
14.
Graham, Roger A., et al.. (1998). Postsurgical Surveillance of Colon Cancer. Annals of Surgery. 228(1). 59–63. 139 indexed citations
15.
Siegfried, J., D.G. Haller, Frank R. Heinzel, et al.. (1998). [Gamma knife radiosurgery in neurosurgery].. PubMed. 128(4). 115–22. 4 indexed citations
16.
Hansen, Richard M., Louise Ryan, Tom Anderson, et al.. (1996). Phase III Study of Bolus Versus Infusion Fluorouracil With or Without Cisplatin in Advanced Colorectal Cancer. JNCI Journal of the National Cancer Institute. 88(10). 668–674. 102 indexed citations
17.
Clark, John L., Ömer Küçük, Donna Neuberg, et al.. (1995). Phase II Trial of Etoposide, Doxorubicin, and Cisplatin Combination in Advanced Measurable Gastric Cancer. American Journal of Clinical Oncology. 18(4). 318–324. 5 indexed citations
18.
Haller, D.G., Myrto Lefkopoulou, John S. Macdonald, & R. Samuel Mayer. (1993). Some Considerations Concerning the Dose and Schedule of 5FU and Leucovorin: Toxicities of two Dose Schedules from the Intergroup Colon Adjuvant Trial (INT-0089). Advances in experimental medicine and biology. 339. 51–56. 11 indexed citations
19.
O’Connell, M., James A. Martenson, Harry S. Wieand, et al.. (1993). Improved therapeutic ratio with protracted venous infusion (PVI) 5-fluorouracil (5FU) during postoperative external beam radiotherapy for high-risk rectal cancer. International Journal of Radiation Oncology*Biology*Physics. 27. 245–246. 5 indexed citations
20.
Whittington, Richard, et al.. (1992). Carcinoma of the extrahepatic biliary system- results of primary therapy. International Journal of Radiation Oncology*Biology*Physics. 24. 212–212. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Théou–Anton Breakdown of academic impact, for papers by Marta Martín-Richard Breakdown of academic impact, for papers by Emmanuelle Samalin Breakdown of academic impact, for papers by Mona Fouad Breakdown of academic impact, for papers by Natsuko Okita Breakdown of academic impact, for papers by Yen‐Yang Chen Breakdown of academic impact, for papers by Fausto Barbieri Breakdown of academic impact, for papers by Nozomu Machida Breakdown of academic impact, for papers by John C. McAuliffe Breakdown of academic impact, for papers by Günther Klautke
Rankless by CCL
2026